… inflammation and inducing the adaptive immune response, these are potential therapeutic
targets … immune response, either to improve the effectiveness of vaccines or control infections. …

… These factors have complicated the development of TLRs as therapeutic targets, and “targeting”
TLRs for cancer therapy may mean exploiting their function by using agonists (eg as a …

… TLRs in infectious diseases, cancers, and autoimmune diseases and therapeutic regimens
… Toll-like receptors are employed as therapeutic targets as well as vaccine adjuvants in viral …

… progression of multiple diseases such as cancer, autoimmune, and inflammatory diseases. In
… in the pathogenesis of inflammatory diseases and how targeting of TLRs offers a promising …

… and signaling mechanisms of Toll-like receptors. A, A typical … Therapeutics targeting
immune-related diseases mediated … cancers, viral infection, immune diseases, and inflammation. …

… immune diseases and cancer. This remarkable ability of TLRs to initiate and … inflammation
makes them attractive therapeutic targets. However, as with many targets for anti-inflammatory …

… therapeutic approach to treat inflammatory diseases. Here we review the therapeutic targets
… in TLR-4 signaling pathways that are critical for suppressing chronic inflammatory disorders. …

… Toll-like receptors (TLRs) are one of these PRRs expressed by various … targeted for
therapeutic drug development for various infectious and inflammatory diseases including cancer. …

… diseases, they have emerged as new therapeutic targets. … risk for inflammatory diseases and
autoimmune disorders, such as … , gastrointestinal inflammation, and even cancer. Evidences …

… Therapeutic targeting of innate immunity with Toll-like … Eritoran suppresses colon cancer
by altering a functional balance in Toll-like receptors that bind lipopolysaccharide. Cancer Res …